Emmanuel Farber

发表

Cell proliferation as a major risk factor for cancer: a concept of doubtful validity.

E. Farber, Emmanuel Farber, 1995, Cancer research.

Gamma-glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis.

E. Farber, A. Malkin, J. Kellen, 1978, Cancer research.

Phenotypic diversity as an early property of putative preneoplastic hepatocyte populations in liver carcinogenesis.

K. Ogawa, D. Solt, E. Farber, 1980, Cancer research.

Cellular adaptation in the origin and development of cancer.

E Farber, E. Farber, H Rubin, 1991, Cancer research.

Possible etiologic mechanisms in chemical carcinogenesis.

E. Farber, Emmanuel Farber, 1987, Environmental health perspectives.

Pre-cancerous steps in carcinogenesis. Their physiological adaptive nature.

E. Farber, Emmanuel Farber, 1984, Biochimica et biophysica acta.

Persistence of resistant putative preneoplastic hepatocytes induced by N-nitrosodiethylamine or N-methyl-N-nitrosourea.

D. Solt, D. Sarma, E. Farber, 1980, Cancer research.

Pathogenesis of experimental liver cancer: comparison with humans.

E. Farber, Emmanuel Farber, 1987, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

Tamoxifen alone or in combination with estradiol-17 beta inhibits the growth and malignant transformation of hepatic hyperplastic nodules.

S. Mishkin, R. Ho, E. Farber, 1985, European journal of cancer & clinical oncology.

Chemical carcinogenesis: a current biological perspective.

E. Farber, Emmanuel Farber, 1984, Carcinogenesis.